Antibody Subclass and Glycosylation Shift Following Effective TB Treatment

With an estimated 25% of the global population infected with Mycobacterium tuberculosis (Mtb), tuberculosis (TB) remains a leading cause of death by infectious diseases. Humoral immunity following TB treatment is largely uncharacterized, and antibody profiling could provide insights into disease res...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Immunol
Hauptverfasser: Grace, Patricia S., Dolatshahi, Sepideh, Lu, Lenette L., Cain, Adam, Palmieri, Fabrizio, Petrone, Linda, Fortune, Sarah M., Ottenhoff, Tom H. M., Lauffenburger, Douglas A., Goletti, Delia, Joosten, Simone A., Alter, Galit
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2021
Schlagworte:
Immunology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8287567/
https://ncbi.nlm.nih.gov/pubmed/34290702
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.679973
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge